Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03938103 · ClinicalTrials.gov registry record · NA
Evaluation of an Enhanced Delivery Model for Go NAPSACC
A NA study of Obesity, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 364
- Enrollment target
- 2
- Study locations
NCT03938103: Completed NA study of Obesity, sponsored by University of North Carolina, Chapel Hill.
NCT03938103 is a NA study of Obesity that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 364 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03938103, a NA study of Obesity, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 364 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study will compare the effectiveness and cost of Basic and Enhanced delivery models for Go NAPSACC on child care centers' use of evidence-based nutrition and physical activity practices. Technical assistance (TA) coaches from Child Care Aware of Kentucky will lead delivery. Half of the TA coaches will deliver Go NAPSACC using the Basic model and the other half will deliver the program using the Enhanced model. It is hypothesized that the Enhanced model will result in greater use of evidence-based nutrition and physical activity practices and will also be more cost effective.
Primary Outcome
Each center's nutrition environment was assessed using the Environment and Policy Assessment and Observation- Self Report (EPAO-SR), a self-report measure filled out through online surveys by child care center directors and preschool classroom teachers. In addition, directors upload a month of menus and policy handbooks, which are reviewed and scored by a trained staff members. An overall nutrition environment score will be derived with scores ranging from 0-3, where higher scores indicate bette
Conditions Studied
Interventions
- BEHAVIORAL Enhanced Go NAPSACC
- BEHAVIORAL Basic Go NAPSACC
Study Locations (2)
Kentucky
- University of Kentucky - Lexington
North Carolina
- UNC Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 364 participants |
| Start Date | 2019-04-10 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT03938103 record still lists
NCT03938103 is an interventional study that assigns participants to a tested intervention. The registered 364 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (56% lower).
The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Go NAPSACC is the first listed.
NCT03938103 reports a single indexed study location in Kentucky, North Carolina.
Frequently Asked Questions
What is clinical trial NCT03938103 about?
NCT03938103 is a clinical study titled "Evaluation of an Enhanced Delivery Model for Go NAPSACC". This study will compare the effectiveness and cost of Basic and Enhanced delivery models for Go NAPSACC on child care centers' use of evidence-based nutrition and physical activity practices. Technical assistance (TA) coaches from Child Care Aware of Kentucky will lead delivery. Half of the TA coach...
What is the current status of trial NCT03938103?
This trial is currently completed. It is a NA study. The enrollment target is 364 participants. The study started on 2019-04-10. Estimated completion is 2022-12-31.
What conditions does trial NCT03938103 study?
This clinical trial studies the following conditions: Obesity.
What interventions are being tested in trial NCT03938103?
The interventions under investigation include: Enhanced Go NAPSACC (BEHAVIORAL), Basic Go NAPSACC (BEHAVIORAL).
Who is sponsoring clinical trial NCT03938103?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03938103 being conducted?
This trial has 2 study locations across Kentucky, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03938103's enrollment target sits among peer trials
364 179th of 1053 higher than 875 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04510597 · 364 participants · Phase 3
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- NCT05098132 · 364 participants · Phase 1
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
- NCT05330221 · 364 participants · NA
Project 2: ACHIEVE- HF
- NCT05673148 · 364 participants · Phase 3
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI